{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:41:07Z","timestamp":1755801667625,"version":"3.44.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,20]]},"DOI":"10.7759\/cureus.90615","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T23:00:56Z","timestamp":1755730856000},"source":"Crossref","is-referenced-by-count":0,"title":["From Blinding Vitreous Hemorrhage to 20\/20: Multimodal Management of Presumed Tubercular Retinal Vasculitis in a Tuberculosis-Endemic Setting"],"prefix":"10.7759","author":[{"given":"Sindy B","family":"Sembiring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea R","family":"Silitonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina La D","family":"Nora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Global Tuberculosis Report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global Tuberculosis Report 2024. World Health Organization, Geneva; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(67)92860-7","article-title":"Ophthalmologic experience in a tuberculosis sanatorium","volume":"64","author":"Donahue HC","year":"1967","unstructured":"Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol. 1967, 64:742-8. 10.1016\/0002-9394(67)92860-7","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.10.001","article-title":"Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis","volume":"67","author":"Alli HD","year":"2022","unstructured":"Alli HD, Ally N, Mayet I, Dangor Z, Madhi SA. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol. 2022, 67:770-92. 10.1016\/j.survophthal.2021.10.001","journal-title":"Surv Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.231","article-title":"Tuberculosis and other causes of uveitis in Indonesia","volume":"32","author":"La Distia Nora R","year":"2018","unstructured":"La Distia Nora R, Sitompul R, Bakker M, et al.. Tuberculosis and other causes of uveitis in Indonesia. Eye (Lond). 2018, 32:546-54. 10.1038\/eye.2017.231","journal-title":"Eye (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1653933","article-title":"Standardization of nomenclature for ocular tuberculosis - results of Collaborative Ocular Tuberculosis Study (COTS) workshop","volume":"28","author":"Agrawal R","year":"2020","unstructured":"Agrawal R, Agarwal A, Jabs DA, et al.. Standardization of nomenclature for ocular tuberculosis - results of Collaborative Ocular Tuberculosis Study (COTS) workshop. Ocul Immunol Inflamm. 2020, 28:74-84. 10.1080\/09273948.2019.1653933","journal-title":"Ocul Immunol Inflamm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2023.100413","article-title":"Clinical manifestation and long-term follow-up of presumed ocular tuberculosis in China","volume":"34","author":"Xie J","year":"2024","unstructured":"Xie J, Qu Y, Qian Z, et al.. Clinical manifestation and long-term follow-up of presumed ocular tuberculosis in China. J Clin Tuberc Other Mycobact Dis. 2024, 34:100413. 10.1016\/j.jctube.2023.100413","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-81-322-2506-5_113-1","article-title":"Cystoid macular edema","author":"Bansal R","year":"2016","unstructured":"Bansal R, Gupta V, Gupta A. Cystoid macular edema. The Uveitis Atlas. Gupta V, Nguyen QD, LeHoang P, Herbort CP (ed): Springer India, New Delhi, India; 2016. 10.1007\/978-81-322-2506-5_113-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200110000-00004","article-title":"PCR-positive tubercular retinal vasculitis: clinical characteristics and management","volume":"21","author":"Gupta A","year":"2001","unstructured":"Gupta A, Gupta V, Arora S, Dogra MR, Bambery P. PCR-positive tubercular retinal vasculitis: clinical characteristics and management. Retina. 2001, 21:435-44. 10.1097\/00006982-200110000-00004","journal-title":"Retina"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002194","article-title":"The collaborative ocular tuberculosis study (COTS)-1. A multinational review of 251 patients with tubercular retinal vasculitis","volume":"39","author":"Gunasekeran DV","year":"2019","unstructured":"Gunasekeran DV, Agrawal R, Agarwal A, et al.. The collaborative ocular tuberculosis study (COTS)-1. A multinational review of 251 patients with tubercular retinal vasculitis. Retina. 2019, 39:1623-30. 10.1097\/IAE.0000000000002194","journal-title":"Retina"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001239","article-title":"Peripheral retinal vasculitis. Analysis of 110 consecutive cases and a contemporary reappraisal of tubercular etiology","volume":"37","author":"Agrawal R","year":"2017","unstructured":"Agrawal R, Gunasekeran DV, Gonzalez-Lopez JJ, et al.. Peripheral retinal vasculitis. Analysis of 110 consecutive cases and a contemporary reappraisal of tubercular etiology. Retina. 2017, 37:112-7. 10.1097\/IAE.0000000000001239","journal-title":"Retina"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-28392-6","article-title":"Pathophysiology of uveitic macular edema","author":"Testi I","year":"2020","unstructured":"Testi I, Rousselot A, Agrawal R, Pavesio C. Pathophysiology of uveitic macular edema. Complications in Uveitis. Francesco Pichi, Piergiorgio Neri (ed): Springer International Publishing, Cham; 2020. 10.1007\/978-3-030-28392-6"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03577-1","article-title":"Uveitic macular oedema in ocular tuberculosis patients in a non-endemic country: characteristics, management, and visual outcomes","volume":"39","author":"Putera I","year":"2025","unstructured":"Putera I, Thiadens AA, Larasmanah AS, et al.. Uveitic macular oedema in ocular tuberculosis patients in a non-endemic country: characteristics, management, and visual outcomes. Eye (Lond). 2025, 39:593-601. 10.1038\/s41433-024-03577-1","journal-title":"Eye (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne JE","year":"2019","unstructured":"Thorne JE, Sugar EA, Holbrook JT, et al.. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019, 126:283-95. 10.1016\/j.ophtha.2018.08.021","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00496875","article-title":"Treatment of Eales' disease with photocoagulation","volume":"194","author":"Spitznas M","year":"1975","unstructured":"Spitznas M, Meyer-Schwicherath G, Stephan B. Treatment of Eales' disease with photocoagulation. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975, 194:193-8. 10.1007\/BF00496875","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.11.1248","article-title":"Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease)","volume":"86","author":"El-Asrar AM","year":"2002","unstructured":"El-Asrar AM, Al-Kharashi SA. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease). Br J Ophthalmol. 2002, 86:1248-51. 10.1136\/bjo.86.11.1248","journal-title":"Br J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000001542","article-title":"Intravitreal faricimab as an adjuvant in the management of tubercular uveitis","volume":"19","author":"Alcibahy Y","year":"2025","unstructured":"Alcibahy Y, Julian K, Bonilla MF, Mohamed A, Amrani S, Agarwal A. Intravitreal faricimab as an adjuvant in the management of tubercular uveitis. Retin Cases Brief Rep. 2025, 19:177-81. 10.1097\/ICB.0000000000001542","journal-title":"Retin Cases Brief Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1404987","article-title":"Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes","volume":"13","author":"Edington M","year":"2017","unstructured":"Edington M, Connolly J, Chong NV. Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes. Expert Opin Drug Metab Toxicol. 2017, 13:1217-24. 10.1080\/17425255.2017.1404987","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396759-from-blinding-vitreous-hemorrhage-to-2020-multimodal-management-of-presumed-tubercular-retinal-vasculitis-in-a-tuberculosis-endemic-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T23:00:56Z","timestamp":1755730856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396759-from-blinding-vitreous-hemorrhage-to-2020-multimodal-management-of-presumed-tubercular-retinal-vasculitis-in-a-tuberculosis-endemic-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.90615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}